Disease/Infection News

RSS

BioAlliance Pharma, Daewoong sign new licensing agreement for commercialization of Sitavig in South Korea

BioAlliance Pharma SA, an innovative Company specialized in the development of drugs in orphan oncology diseases, today announces an exclusive supply and license agreement for Sitavig® (Acyclovir Lauriad®) with Daewoong Pharmaceutical Co., Ltd. for commercialization rights in South Korea.

2 Apr 2014

Fewer blood transfusions reduce infection rates by nearly 20%

Blood transfusions are among the most common treatments for hospitalized patients nationwide, but doing them less often reduces infection rates by nearly 20 percent, according to a study in the Journal of the American Medical Association co-authored by Neil Blumberg, M.D., professor at the University of Rochester School of Medicine and Dentistry.

2 Apr 2014

Study shows important parallels between epidemic of HIV/AIDS and opioid addiction

There are important parallels between the early years of the HIV/AIDS epidemic and the current epidemic of opioid addiction - ones that could trigger a significant shift in opioid addiction prevention, diagnosis and treatment.

2 Apr 2014

Physician offers tips to prevent tick bites

Warmer temperatures and longer days beckon outdoors enthusiasts and gardeners alike to get out and enjoy the season.

2 Apr 2014

Cedars-Sinai earns grant to conduct clinical trial of gene therapy product for patients with Lou Gehrig's disease

The Cedars-Sinai Regenerative Medicine Institute has received a $2.5 million grant from the Department of Defense to conduct animal studies that, if successful, could provide the basis for a clinical trial of a gene therapy product for patients with Lou Gehrig's disease, also called amyotrophic lateral sclerosis, or ALS.

2 Apr 2014

EPFL scientists develop computer tool to identify mutations that make influenza resistant to Tamiflu

Tamiflu is one of the few available treatments for those who come down with the flu. But the virus quickly develops resistance; multiplying at a rate of several generations a day, these tiny pathogens rapidly accumulate genetic mutations. Because of this, they have a good chance of developing counterattacks to the antiviral. How can these infinitesimal variations be identified within the immensity of the virus' genetic code? EPFL researchers have created a computer tool that can shed light on the flu virus' formidable adaptability.

1 Apr 2014

Novel proteins may lead to new ways to combat venereal disease

Researchers at Oregon State University have discovered novel proteins in, or on the surface of the bacteria that causes gonorrhea, which offer a promising new avenue of attack against a venereal disease that is showing increased resistance to the antibiotics used to treat it.

1 Apr 2014

Men with long-term HIV infections at higher risk of developing plaque in their coronary arteries

Men with long-term HIV infections are at higher risk than uninfected men of developing plaque in their coronary arteries, regardless of their other risk factors for coronary artery disease, according to results of a study led by Johns Hopkins researchers. A report on the research appears in the April 1 issue of Annals of Internal Medicine.

1 Apr 2014

NeuroVive presents clinical data of NVP018 for treatment of chronic hepatitis B infections at EASL

NeuroVive's anti-viral preclinical program, with compound designated NVP018, has generated significant data indicating that NVP018 has the potential to become an effective alternative or addition to current drugs for treating chronic hepatitis B infections.

29 Mar 2014

Stigmatization may do more harm than good for modern humans, say researchers

Stigmatization may have once served to protect early humans from infectious diseases, but that strategy may do more harm than good for modern humans, according to Penn State researchers.

29 Mar 2014

Researchers develop potentially safer and more cost-effective therapeutics against West Nile virus

An international research group led by Arizona State University professor Qiang "Shawn" Chen has developed a new generation of potentially safer and more cost-effective therapeutics against West Nile virus and other pathogens.

29 Mar 2014

TSRI scientists receive $2.3M to study viruses that cause tropical diseases

The outbreak of dengue fever that infected some 20 people in Florida's Martin County late last year unnerved many who feared the tropical disease had once again established a foothold in Florida. The last outbreaks occurred in 2009 and 2010 in Key West—before that, the disease hadn't struck Florida in more than 70 years.

28 Mar 2014

Simple chip-based method for better diagnosis of parasitic infections

Parasitic infections like malaria and sleeping sickness affect hundreds of millions of people, primarily in the poorest regions of the world. Diagnosis of these diseases is often difficult because the concentration of parasites in the blood can be very low.

28 Mar 2014

New policy report on multi-drug resistant tuberculosis

Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice’s multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.

28 Mar 2014

CDC identifies six new cases of people with Heartland virus

The Centers for Disease Control and Prevention in collaboration with health officials in Missouri and Tennessee have identified six new cases of people sick with Heartland virus: five in Missouri and one in Tennessee. The new cases, discovered in 2012 and 2013, are described today in CDC's Morbidity and Mortality Weekly Report.

28 Mar 2014

New biomarker test accurately estimates mortality risk in patients with septicemia

Septic shock is a severe systemic infection and major cause of death for the old and young alike. Unfortunately, researchers say testing new drug regimens to stop the infection is confounded because clinical trials include patients who are either too sick to be saved by experimental therapies or not sick enough to warrant the treatments.

27 Mar 2014

Experimental vaccine for HSV-2 infection reduces rate of viral shedding at 6 months

Updated Phase 1/2a results with GEN-003, a vaccine candidate under development by Genocea Biosciences, Inc. (Nasdaq: GNCA) for the treatment of herpes simplex virus type 2 (HSV-2) infection, showed the experimental vaccine to generate highly significant reductions in both the number of clinical lesion days and rate of viral shedding at six months after the final vaccine dose.

27 Mar 2014

Johns Hopkins researchers identify protein that regulates the body's immune response to CMV

Infectious disease specialists at the Johns Hopkins Children's Center have identified a protein that regulates the body's immune response to cytomegalovirus (CMV), a common pathogen that causes lifelong infections and can lead to devastating illness in newborns and those with weakened immune systems.

27 Mar 2014

Men having sex with men use Internet to find sexual partners who do not identify as gay

Online sexual hook-ups present a unique opportunity to explore many factors of decision-making that inform sexual health. A study conducted by Eric Schrimshaw, PhD, at Columbia University's Mailman School of Public Health and Martin J. Downing, Jr., PhD, of the National Development and Research Institutes, found evidence that men having sex with men use the Internet to find sexual partners who do not identify as gay, either to fulfill a fantasy or because it allows anonymous sexual encounters without discovery.

26 Mar 2014

Emergence of community-acquired infections due to ESBL-producing bacteria on the rise

The emergence of community-acquired infections, such as urinary tract infections (UTI), due to strains resistant to common antibiotics are on the rise, according to Rhode Island Hospital researchers. The study is published online in the journal Antimicrobial Resistance and Infection Control.

26 Mar 2014

Disease/Infection News

BioAlliance Pharma, Daewoong sign new licensing agreement for commercialization of Sitavig in South Korea

Fewer blood transfusions reduce infection rates by nearly 20%

Study shows important parallels between epidemic of HIV/AIDS and opioid addiction

Physician offers tips to prevent tick bites

Cedars-Sinai earns grant to conduct clinical trial of gene therapy product for patients with Lou Gehrig's disease

EPFL scientists develop computer tool to identify mutations that make influenza resistant to Tamiflu

Novel proteins may lead to new ways to combat venereal disease

Men with long-term HIV infections at higher risk of developing plaque in their coronary arteries

NeuroVive presents clinical data of NVP018 for treatment of chronic hepatitis B infections at EASL

Stigmatization may do more harm than good for modern humans, say researchers

Researchers develop potentially safer and more cost-effective therapeutics against West Nile virus

TSRI scientists receive $2.3M to study viruses that cause tropical diseases

Simple chip-based method for better diagnosis of parasitic infections

New policy report on multi-drug resistant tuberculosis

CDC identifies six new cases of people with Heartland virus

New biomarker test accurately estimates mortality risk in patients with septicemia

Experimental vaccine for HSV-2 infection reduces rate of viral shedding at 6 months

Johns Hopkins researchers identify protein that regulates the body's immune response to CMV

Men having sex with men use Internet to find sexual partners who do not identify as gay

Emergence of community-acquired infections due to ESBL-producing bacteria on the rise

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News